Delivery Order SPE2DB20D2104-SPE2DB23FT38A

Award Date 5/4/23
Potential Completion Date 5/25/23
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of TASIGNA 150 MG CAPSULE 28S. The contract is a firm fixed-price delivery order with a ceiling value of $5,624.62 and has a period of performance through October 16, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a broader Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,638.02, is for the delivery of TASIGNA 150 MG CAPSULE 28S, a prescription medication. The contract has a period of performance through March 24, 2025 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,249.24 firm fixed price contract is for the delivery of 4564661028 - TASIGNA 150 MG CAPSULE 28S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical. The IDC provides a comprehensive range of pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4559658209 units of TASIGNA 150 MG CAPSULE 28S, with a firm fixed-price ceiling value of $11,249.24. The award date is January 19, 2023, and the ultimate completion date is February 9, 2023. This contract is not designated as a set-aside and is an open competition award....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of TASIGNA 150 MG CAPSULE 28S. The firm-fixed-price contract has a ceiling value of $5,624.62 and an ultimate completion date of November 22, 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of TASIGNA 150 MG CAPSULE 28S. The contract has a ceiling value of $5,624.62 and is a firm fixed price, delivery order contract with a completion date of September 24, 2024. AmerisourceBergen, a major pharmaceutical distributor, will provide these specialty medication capsules to support military treatment programs and other federal healthcare requirements. This...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp (Corporate Office Division) for the supply of TASIGNA 150 MG CAPSULE 28S. The contract has a ceiling value of $5,624.62 and a period of performance through September 30, 2024. It is a firm fixed-price contract with no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, is the prime contractor for this award. The contract is part of a larger Indefinite...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $5,624.62 firm fixed-price contract is for the delivery of TASIGNA 150 MG CAPSULE 28S, a specialty pharmaceutical product. The contract has an ultimate completion date of April 12, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of TASIGNA 50 MG CAPSULE 120S, a pharmaceutical product, at a ceiling value of $17,457.03. The contract has a final completion date of February 24, 2025. AmerisourceBergen is the prime contractor, and the contract is a Firm Fixed Price type with no...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,819.01 firm fixed-price contract is for the supply of TASIGNA 150 MG CAPSULE 28S, a specialty medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB23FT38A
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TASIGNA 150 MG CAPSULE 28S, a pharmaceutical product. The contract has a firm fixed price and a ceiling value of $11,249.24. The performance period runs through May 25, 2023. This contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.

Generated 2/27/25, 9:54 AM